LATESTS NEWS FROM ACTALAB

Besponsa: descrizione e gestione di specifiche reazioni avverse

3 settimane ago

Inotuzumab Ozogamicin verso Terapia Standard per la Leucemia Linfoblastica Acuta

Obinotuzumab in the treatment of Chronic Lymphocytic Leukemia

E’ oggi possibile prevedere nei soggetti anziani l’insorgenza di leucemia mieloide acuta?

Varianti germinali dc IKZF1 predispongono allo sviluppo della LAL nei bambini

The effects of catechins on related risk factors with Type 2 diabetes: a review

Influences of Physalis peruviana L. and Lupinus albus L. fruits extracts on the levels of some biochemical parameters in brain and muscle tissues of type II diabetic rats

Malnutrition rate among hospitalized patients with type 2 diabetes mellitus

Malnutrition rate among hospitalized patients with type 2 diabetes mellitus

Clearance of somatic mutations at remission and the risk of relapse in AML

Besponsa: descrizione e gestione di specifiche reazioni avverse

Read More

Recurrence of prostate cancer after HIFU. Proposal of a novel predictive index

Surgical therapy of cutaneous squamous cell carcinoma: our experience

FNA Cytology in pediatric small cell glioblastoma

Besponsa: descrizione e gestione di specifiche reazioni avverse

Inotuzumab Ozogamicin verso Terapia Standard per la Leucemia Linfoblastica Acuta

Obinotuzumab in the treatment of Chronic Lymphocytic Leukemia

#Follow us on Facebook